Enrollment open • Combination therapy • Metastases
|
ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HER-2 positive • HR positive • HER-2 mutation • HER-2 expression • ER positive + PGR positive
|
Herceptin (trastuzumab) • Enhertu (fam-trastuzumab deruxtecan-nxki) • DS-1103